引用本文:
【打印本页】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 5217次   下载 3907 本文二维码信息
码上扫一扫!
分享到: 微信 更多
非小细胞肺癌患者DC-CIK过继免疫治疗前后外周血TLR4表达的变化
王细勇, 袁琳娜, 张志豪
武警浙江总队嘉兴医院胸心外科
摘要:
目的观察细胞因子诱导的杀伤细胞(DC-CIK)过继免疫治疗前后非小细胞肺癌(NSCLC)患者外周血单个核细胞(PBMC)Toll样受体4(TLR4)mRNA表达变化,及脂多糖刺激下PBMC分泌细胞因子的变化,探讨TLR4在DC-CIK过继免疫治疗中的作用。方法对50例采用DC-CIK治疗的NSCLC患者,运用RT-PCR检测治疗前后PBMCTLR4mRNA表达变化,ELISA法检测治疗前后NSCLC患者PBMC在脂多糖刺激下细胞因子(IL-6、IL-8及TNF-α)分泌的变化。结果DC-CIK治疗后NSCLC患者PBMCTLR4mRNA的表达水平较治疗前显著降低(t=6.272,P<0.01);脂多糖刺激下PBMC分泌IL-6(t=17.407,P<0.01)、IL-8(t=15.244,P<0.01)及TNF-α(t=12.428,P<0.01)显著减少。结论DC-CIK过继免疫治疗可能通过降低PBMCTLR4mRNA的表达,提高机体抗肿瘤免疫功能。
关键词:  树突状细胞 细胞因子诱导的杀伤细胞 非小细胞肺癌 TLR4
DOI:10.12056/j.issn.1006-2785.2017.39.7.2015-1401
分类号:
基金项目:
Changes of TLR4 mRNA expression in peripheral blood of patients with non-small cell lung cancer after DC-CIK immunotherapy
WANG Xiyong, YUAN Linna, ZHANG Zhihao
Jiaxing Armed Police Corps Hosptial
Abstract:
Objective To investigate the changes of TLR4 mRNA expression in peripheral blood mononuclear cell (PBMC) of patients with non-small cell lung cancer(NSCLC) after DC-CIK immunotherapy. Methods The mRNA expression of TLR4 in PBMC was detected by reverse transcription PCR (PT-PCR) in 50 patients with NSCLC before and after DC-CIK therapy. The secretion of cytokines (IL-6, IL-8 and TNF-α) of PBMC stimulated with LPS was detected by ELISA before and after DC-CIK therapy. Results After DC-CIK treatment, the relative expression level of TLR4 mRNA in PBMC of NSCLC patients was significantly decreased(t=6.272, P<0.01), the secretion of IL-6(t=17.407, P<0.01), IL-8 (t=15.244, P<0.01) and TNF-α (t=12.428, P<0.01) by PBMC stimulated with LPS was significantly decreased. Conclusion DC-CIK immunotherapy can down-regulate TLR4 expression in PBMC of NSCL patients to enhance the anti-tumor immunity.
Key words:  Dendritic cells(DC) Cytokine-induced killer(CIK) Non-small cell lung cancer TLR4